RCM
IMGN

RA Capital Management’s Immunogen Inc IMGN Stock Holding History

RA Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,750,601
Closed -$704M – 82
2023
Q4 		$704M Buy
23,750,601
+10,428,313
+78% +$208M 11% 2
2023
Q3 		$211M Buy
13,322,288
+10,992,330
+472% +$183M 4.16% 4
2023
Q2 		$44M Sell
2,329,958
-19,524,000
-89% -$231M 0.83% 35
2023
Q1 		$83.9M Hold
21,853,958
– – 1.9% 19
2022
Q4 		$108M Buy
21,853,958
+112,500
+0.5% +$610K 2.2% 17
2022
Q3 		$104M Hold
21,741,458
– – 2.22% 13
2022
Q2 		$97.8M Hold
21,741,458
– – 2.61% 9
2022
Q1 		$103M Buy
21,741,458
+1,500,000
+7% +$8.3M 2.26% 10
2021
Q4 		$150M Buy
20,241,458
+1,824,000
+10% +$11.3M 2.65% 7
2021
Q3 		$104M Hold
18,417,458
– – 1.45% 22
2021
Q2 		$121M Hold
18,417,458
– – 1.95% 11
2021
Q1 		$149M Hold
18,417,458
– – 2.25% 11
2020
Q4 		$119M Buy
18,417,458
+11,376,973
+162% +$66.4M 1.66% 16
2020
Q3 		$25.3M Buy
+7,040,485
New +$28.4M 0.46% 45
2020
Q2 		– Sell
-5,166,303
Closed -$17.6M – 64
2020
Q1 		$17.6M Buy
+5,166,303
New +$22.6M 0.56% 36

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

RA Capital Management's IMGN Position: Q1 2024 in Review

RA Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 23,750,601 shares — an estimated $704M sold.

RA Capital Management first reported a position in IMGN in Q1 2020 and held it in 15 quarters. The position peaked at $704M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • RA Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • RA Capital Management sold 23,750,601 Immunogen Inc shares in Q1 2024, an estimated $704M.
  • RA Capital Management first reported a position in Immunogen Inc in Q1 2020 and held it in 15 quarters.
  • RA Capital Management's Immunogen Inc position peaked at $704M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on RA Capital Management's 13F filing for Q1 2024, filed 15 May 2024.